financetom
Market
financetom
/
Market
/
Japan's Nikkei falls as investors take profits ahead of corporate earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Nikkei falls as investors take profits ahead of corporate earnings
Jul 27, 2025 7:47 PM

TOKYO, July 28 (Reuters) - Japan's Nikkei share average

erased early gains to trade lower on Monday, as investors locked

in profits following a recent rally and shifted their focus to

upcoming corporate earnings.

As of 0217 GMT, the Nikkei was down 0.8% at 41,115.60, after

rising as much as 0.2% earlier in the session.

The broader Topix slipped 0.45% at 2,938.55.

"Investors sold stocks to book profits from a recent rally;

that's a short answer to today's declines," said Seiichi Suzuki,

chief equity market analyst at Tokai Tokyo Intelligence

Laboratory.

"But they sold stocks because the shares jumped last week,

and were concerned that corporate earnings may not justify the

current level of the equities."

The Nikkei climbed to a one-year high last week after Japan

and the United States struck a deal to lower the hefty tariffs

U.S. President Donald Trump threatened to impose on goods from

Japan.

Chip-related shares led the declines, with Advantest ( ADTTF )

slipping 7.66% to become the biggest drag for the

Nikkei.

Screen Holdings ( DINRF ) fell 7.24% after the chip-making

equipment maker reported a 12.2% decline in its latest quarterly

operating profit.

The banking sector fell 1.78% to become the worst

performer among the Tokyo Stock Exchange's 33 industry

sub-indexes.

Bucking the trend, Fanuc jumped 5.6% to become the top

percentage gainer in the Nikkei, after the robot maker's latest

quarterly operating profit jumped nearly 30%. The company also

said that its forecast factored in the 15% U.S. tariff set to

take effect on August 1.

Of the more than 1,600 stocks trading on the TSE's prime

section, 46% rose and 49% fell, with 4% trading flat.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved